Patents Assigned to InGeneron, Inc.
  • Patent number: 11369716
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of care, which include isolated cell populations that are enriched with stem cells and are mixed with biological fillers including hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: June 28, 2022
    Assignees: INGENERON, INC., Board of Regents, The University of Texas System
    Inventors: Andrew M Altman, Eckhard U. Alt, Michael E. Coleman
  • Patent number: 10905722
    Abstract: Adult stem cells are reprogrammed to form pacemaker cells and Purkinje cells through the sequential activation of SHOX2>TBX5>HCN2. These Purkinje cells spontaneously surround and connect with the larger pacemaker cells, thus forming an induced sinoatrial body that produces funny current and can make cardiovascular tissues beat in a manner similar to a natural sinoatrial node.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: February 2, 2021
    Assignees: INGENERON INC., ALLIANCE OF CARDIOVASCULAR RESEARCHERS
    Inventors: Eckhard Alt, Tahereh Karimi
  • Patent number: 10760059
    Abstract: Methods of differentiating unmodified adult stem cells into functional beta-like cells are provided, as well as compositions, tissues and devices containing such cells. The method requires inducing sequential expression of PDX1, NGN3, and MAFA in these stem cells to form reprogrammed beta cells. Methods of treating diabetes are also provided, comprising obtaining stem cells, preferably from a patient with diabetes, inducing sequential expression of PDX1, NGN3, and MAFA, in said stem cells to form reprogrammed beta cells, and introducing said reprogrammed beta cells into a pancreas of said patient. Alternatively, it may be possible to inject such cells systemically, if the cells are targeted for the pancreas. In yet another embodiment, the reprogrammed beta cells are placed into an artificial pancreas that is surgically placed or injected into the patient.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: September 1, 2020
    Assignee: InGeneron Inc.
    Inventors: Eckhard U. Alt, Tahereh Karimi
  • Publication number: 20190175787
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of care, which include isolated cell populations that are enriched with stem cells and are mixed with biological fillers including hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Application
    Filed: February 21, 2019
    Publication date: June 13, 2019
    Applicants: Board of Regents, The University of Texas System, Ingeneron, Inc.
    Inventors: Andrew M. Altman, Eckhard U. Alt, Michael E. Coleman
  • Patent number: 10238770
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of care, which include isolated cell populations that are enriched with stem cells and are mixed with biological fillers including hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: March 26, 2019
    Assignees: Ingeneron, Inc., Board of Regents, The university of Texas System
    Inventors: Andrew M Altman, Eckhard U. Alt, Michael E. Coleman
  • Patent number: 9913865
    Abstract: Adult stem cells are reprogrammed to form pacemaker cells and Purkinje cells through the sequential activation of SHOX2>TBX5>HCN2. These Purkinje cells spontaneously surround and connect with the larger pacemaker cells, thus forming an induced sinoatrial body that produces funny current and can make cardiovascular tissues beat in a manner similar to a natural sinoatrial node.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: March 13, 2018
    Assignees: InGeneron Inc., Alliance of Cardiovascular Research
    Inventors: Eckhard Alt, Tahereh Karimi
  • Publication number: 20170224736
    Abstract: Methods for the extraction and processing of umbilical stem cells for therapeutic and diagnostic purposes are disclosed. The methods provide high regenerative cell numbers and high cell viability. Further, the methods do not require culturing the cells in serum or growth factors. Certain aspects of the present invention concern methods of processing tissue for use in regenerative medicine. In another aspect of the invention, the tissue is processed and the resulting cell preparation administered within one and the same medical procedure.
    Type: Application
    Filed: July 31, 2015
    Publication date: August 10, 2017
    Applicant: Ingeneron, Inc.
    Inventors: Eckhard U Alt, Ivonne Guzman Bruno, Timo Nazari Shafti, Michael E Coleman, Anita Kadala
  • Patent number: 9663762
    Abstract: Methods for recovering target cells using degradable three dimensional matrices are described.
    Type: Grant
    Filed: May 16, 2013
    Date of Patent: May 30, 2017
    Assignee: Ingeneron, Inc.
    Inventors: Michael Coleman, Jody Vykoukal
  • Publication number: 20170088623
    Abstract: This document provides prophylactic methods for reducing cancer metastasis by targeting LCN2, MMP9, and CX-CR4.
    Type: Application
    Filed: September 30, 2015
    Publication date: March 30, 2017
    Applicants: Ingeneron, Inc., Board of Regents, The University of Texas System
    Inventors: Eckhard U. Alt, Ralph B. Arlinghaus, Michael E. Coleman
  • Publication number: 20160158292
    Abstract: Methods for the extraction and processing of umbilical stem cells for therapeutic and diagnostic purposes are disclosed. The methods provide high regenerative cell numbers and high cell viability. Further, the methods do not require culturing the cells in serum or growth factors.
    Type: Application
    Filed: July 31, 2015
    Publication date: June 9, 2016
    Applicant: Ingeneron, Inc.
    Inventors: Eckhard Alt, Ivonne Guzman Bruno, Timo Nazari Shafti, Michael E Coleman, Anita Kadala
  • Publication number: 20160051729
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of care, which include isolated cell populations that are enriched with stem cells and are mixed with biological fillers including hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Application
    Filed: November 2, 2015
    Publication date: February 25, 2016
    Applicants: Ingeneron, Inc., Board of Regents, The University of Texas System
    Inventors: Andrew M Altman, Eckhard U. Alt, Michael E. Coleman
  • Patent number: 9173975
    Abstract: Methods are described for generating autologous tissue grafts, including generating grafts at the point of care, which include isolated cell populations that are enriched with stem cells and are mixed with hyaluronic acid and derivatives thereof. The hyaluronic acid localizes the cells to a desired injection site and stimulates collagen production thus enhancing the viability and the longevity of the graft.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: November 3, 2015
    Assignees: Ingeneron, Inc., Board of Regents, The University of Texas System
    Inventors: Andrew M. Altman, Eckhard U. Alt, Michael E. Coleman
  • Publication number: 20150093809
    Abstract: This document describes methods and an apparatus for recovery of a cell-enriched matrix and cells (e.g., regenerative cells) from a tissue sample. In some embodiments, at least two rounds of acceleration and deceleration are performed.
    Type: Application
    Filed: September 27, 2013
    Publication date: April 2, 2015
    Applicant: InGeneron, Inc.
    Inventors: Eckhard U. Alt, Ron Stubbers, Michael E. Coleman
  • Publication number: 20150037387
    Abstract: Apparatus and methods are described for generating autologous tissue grafts, the apparatus including a point of care SVF isolation unit that includes a tissue digestion chamber in fluid communication with a lipid separating chamber, whereby SVF cells are isolated without centrifugation; and a cell seeding chamber in fluid communication with the SVF isolation unit, said cell seeding chamber adapted to support a cell scaffold. Methods and materials for cell seeding, including through the provision of micro rough scaffold surfaces, are also provided.
    Type: Application
    Filed: October 20, 2014
    Publication date: February 5, 2015
    Applicants: Board of Regents of the University of Texas System, Ingeneron, Inc.
    Inventors: Michael E. Coleman, Eckhard U. Alt, Ron Stubbers
  • Patent number: 8865199
    Abstract: Apparatus and methods are described for generating autologous tissue grafts, the apparatus including a point of care SVF isolation unit that includes a tissue digestion chamber in fluid communication with a lipid separating chamber, whereby SVF cells are isolated without centrifugation; and a cell seeding chamber in fluid communication with the SVF isolation unit, said cell seeding chamber adapted to support a cell scaffold. Methods and materials for cell seeding, including through the provision of micro rough scaffold surfaces, are also provided.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: October 21, 2014
    Assignees: Ingeneron, Inc., Board of Regents of the University of Texas System
    Inventors: Michael E. Coleman, Eckhard U. Alt, Ron Stubbers
  • Publication number: 20130337551
    Abstract: A unitary apparatus for isolating cells from adipose tissue including a lipid separation processor with a dispersing head equipped with a plurality of ports and a digestion chamber for dissociation of the constituent cells disposed in adipose tissue. The lipid separating apparatus is useful for the separation of lipids and adipocytes from a mixed cell population. A cell seeding chamber may be attached to the cell isolation apparatus. The components of the apparatus may be packaged in modular kit form.
    Type: Application
    Filed: October 26, 2012
    Publication date: December 19, 2013
    Applicant: InGeneron Inc.
    Inventors: Ron Stubbers, Michael Coleman
  • Patent number: 8309342
    Abstract: A unitary apparatus for isolating cells from adipose tissue including a lipid separation processor with a dispersing head equipped with a plurality of ports and a digestion chamber for dissociation of the constituent cells disposed in adipose tissue. The lipid separating apparatus is useful for the separation of lipids and adipocytes from a mixed cell population. A cell seeding chamber may be attached to the cell isolation apparatus. The components of the apparatus may be packaged in modular kit form.
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: November 13, 2012
    Assignee: InGeneron, Inc.
    Inventors: Ron Stubbers, Michael E. Coleman
  • Publication number: 20120224053
    Abstract: Optical detection platforms are described as well as methods of using such platforms to perform quantitative assays.
    Type: Application
    Filed: June 17, 2010
    Publication date: September 6, 2012
    Applicants: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, INGENERON, INC.
    Inventors: Jody Vykoukal, Daynene M. Vykoukal, Gregory P. Stone, Eckhard U. Alt
  • Publication number: 20120219561
    Abstract: This document provides prophylactic methods for reducing cancer metastasis by targeting LCN2, MMP9, and CX-CR4.
    Type: Application
    Filed: August 2, 2010
    Publication date: August 30, 2012
    Applicants: Ingeneron, Inc., Board of Regents, The University of Texas System
    Inventors: Eckhard U. Alt, Ralph B. Arlinghaus, Michael E. Coleman
  • Publication number: 20100310527
    Abstract: Methods and compositions are provided for lineage predetermination of cellular transplants including through liposome mediated transfection with aqueous protein extracts from populations of differentiated mammalian cells, or cellular fractions thereof, wherein the differentiated mammalian cells are enriched in one or more of adipocytes, chondrocytes, endothelial cells, hepatocytes, cardiomyocytes, smooth muscle cells, skeletal muscle cells, cardiac pacemaker cells, Schwann cells, pancreatic islet cells, hematopoietic cells, myeloblasts, neurons, and osteoblasts.
    Type: Application
    Filed: January 8, 2010
    Publication date: December 9, 2010
    Applicants: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, INGENERON, INC.
    Inventors: Eckhard U. Alt, Kirstin Schimrosczyk, Michael E. Coleman